Identification of novel mutational drivers reveals oncogene dependencies in multiple myelomaBrian A. Walker, Gareth J. Morgan, Adam Rosenthal et al.|Blood|2018Cited by 492
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysisBrian A. Walker, Gareth J. Morgan, Konstantinos Mavrommatis et al.|Leukemia|2018Cited by 452
Rate of CRL4CRBN substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4Chad C. Bjorklund, Anjan Thakurta|Blood Cancer Journal|2015Cited by 216